Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Qiaoru Guo"'
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-17 (2024)
Abstract To address immune escape, multi-specific CAR-T-cell strategies use natural ligands that specifically bind multiple receptors on malignant cells. In this context, we propose a split CAR design comprising a universal receptor expressed on T ce
Externí odkaz:
https://doaj.org/article/941c6678201d4fd19bf85503ed33843a
Autor:
Chaoyue Su, Hui Wang, Yunru Liu, Qiaoru Guo, Lingling Zhang, Jiajun Li, Wenmin Zhou, Yanyan Yan, Xinke Zhou, Jianye Zhang
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Currently, immunotherapy has shown great efficacy in clinical trials, and monoclonal antibodies directed against immune checkpoint PD-1/PD-L1 have shown encouraging results in first-line or second-line treatment of non-small cell lung cancer patients
Externí odkaz:
https://doaj.org/article/58ab731872ca415eb6ec8fd152e7b269
Autor:
Da-Bao Chen, Yan Wang, Qiaoru Guo, Xinquan Li, Guangyun Wang, Wei-Ting Xuan, Hang Song, Hua-Wu Gao, Biao Cai
Publikováno v:
Journal of Alzheimer's Disease. 78:1315-1338
It is widely recognized that Alzheimer’s disease (AD) has a complicate link to renin-angiotensin system (RAS). It is known that cerebrovascular disease has some connections with AD, but most of the studies are still conducted in parallel or indepen
Publikováno v:
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences. 47(2)
Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer, with highmorbidity and mortality rate. Nove drug development for NSCLC is urgently needed.This study aims to investigate the activity of lathyrol derivatives and the mechanism fo
Autor:
YanRui Pan, Hui Wang, ChaoYue Su, LingLing Zhang, QiaoRu Guo, YanYan Yan, JiaJun Li, JiaLi Fu, XinYue Fan, YuQing Wang, JianYe Zhang
Publikováno v:
Cancer Advances. 3:101